{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T04:08:07Z","timestamp":1747973287040,"version":"3.41.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12029-025-01219-7","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T09:33:17Z","timestamp":1747906397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gastric Carcinoma Patients with Advanced Pathological Lymph Node Stage Benefit from Postoperative Radiotherapy: A Retrospective Analysis"],"prefix":"10.1007","volume":"56","author":[{"given":"Guangmin","family":"Wan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"issue":"3","key":"1219_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"1219_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1470-2045(10)70070-X","volume":"11","author":"I Songun","year":"2010","unstructured":"Songun I, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11(5):439\u201349.","journal-title":"Lancet Oncol"},{"issue":"5","key":"1219_CR3","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/01.sla.0000143245.28656.15","volume":"240","author":"M D'Angelica","year":"2004","unstructured":"D\u2019Angelica M, et al. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004;240(5):808\u201316.","journal-title":"Ann Surg"},{"key":"1219_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ejca.2017.04.027","volume":"81","author":"M Stahl","year":"2017","unstructured":"Stahl M, et al. Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial. Eur J Cancer. 2017;81:183\u201390.","journal-title":"Eur J Cancer"},{"issue":"2","key":"1219_CR5","doi-asserted-by":"publisher","first-page":"102226","DOI":"10.1016\/j.esmoop.2023.102226","volume":"9","author":"K Shitara","year":"2024","unstructured":"Shitara K, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer. ESMO Open. 2024;9(2):102226.","journal-title":"ESMO Open"},{"issue":"10","key":"1219_CR6","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick F, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(10):1005\u201320.","journal-title":"Ann Oncol"},{"issue":"1","key":"1219_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12957-018-1490-7","volume":"16","author":"N Zhang","year":"2018","unstructured":"Zhang N, et al. Progress of preoperative and postoperative radiotherapy in gastric cancer. World J Surg Oncol. 2018;16(1):187.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"1219_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5230\/jgc.2023.23.e11","volume":"23","author":"TH Kim","year":"2023","unstructured":"Kim TH, et al. Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach. J Gastric Cancer. 2023;23(1):3\u2013106.","journal-title":"J Gastric Cancer"},{"issue":"10","key":"1219_CR9","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa010187","volume":"345","author":"JS Macdonald","year":"2001","unstructured":"Macdonald JS, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725\u201330.","journal-title":"N Engl J Med"},{"issue":"12","key":"1219_CR10","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1245\/s10434-017-6048-3","volume":"24","author":"VKY Ho","year":"2017","unstructured":"Ho VKY, et al. Adjuvant chemoradiotherapy for non-pretreated gastric cancer. Ann Surg Oncol. 2017;24(12):3647\u201357.","journal-title":"Ann Surg Oncol"},{"issue":"19","key":"1219_CR11","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1200\/JCO.2011.36.7136","volume":"30","author":"SR Smalley","year":"2012","unstructured":"Smalley SR, et al. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol. 2012;30(19):2327\u201333.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1219_CR12","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.annonc.2020.11.004","volume":"32","author":"WO de Steur","year":"2021","unstructured":"de Steur WO, et al. Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial. Ann Oncol. 2021;32(3):360\u20137.","journal-title":"Ann Oncol"},{"issue":"5","key":"1219_CR13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/S1470-2045(18)30132-3","volume":"19","author":"A Cats","year":"2018","unstructured":"Cats A, et al. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. Lancet Oncol. 2018;19(5):616\u201328.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1219_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11\u201320.","journal-title":"N Engl J Med"},{"issue":"3","key":"1219_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1200\/JCO.2011.39.1953","volume":"30","author":"J Lee","year":"2012","unstructured":"Lee J, et al. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol. 2012;30(3):268\u201373.","journal-title":"J Clin Oncol"},{"issue":"28","key":"1219_CR16","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1200\/JCO.2014.58.3930","volume":"33","author":"SH Park","year":"2015","unstructured":"Park SH, et al. Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the adjuvant chemoradiotherapy in stomach tumors trial, including survival and subset analyses. J Clin Oncol. 2015;33(28):3130\u20136.","journal-title":"J Clin Oncol"},{"issue":"21","key":"1219_CR17","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252\u20139.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1219_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivariate Behav Res"},{"issue":"13","key":"1219_CR19","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","volume":"29","author":"M Ychou","year":"2011","unstructured":"Ychou M, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29(13):1715\u201321.","journal-title":"J Clin Oncol"},{"issue":"10184","key":"1219_CR20","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"SE Al-Batran","year":"2019","unstructured":"Al-Batran SE, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet. 2019;393(10184):1948\u201357.","journal-title":"Lancet"},{"issue":"6","key":"1219_CR21","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1200\/JCO.2008.17.0506","volume":"27","author":"M Stahl","year":"2009","unstructured":"Stahl M, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol. 2009;27(6):851\u20136.","journal-title":"J Clin Oncol"},{"issue":"28","key":"1219_CR22","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1200\/JCO.2005.14.621","volume":"23","author":"DD Smith","year":"2005","unstructured":"Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23(28):7114\u201324.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1219_CR23","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1097\/SLA.0000000000002444","volume":"268","author":"YHM Claassen","year":"2018","unstructured":"Claassen YHM, et al. Surgicopathological quality control and protocol adherence to lymphadenectomy in the CRITICS gastric cancer trial. Ann Surg. 2018;268(6):1008\u201313.","journal-title":"Ann Surg"},{"issue":"2","key":"1219_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10120-016-0601-9","volume":"20","author":"T Sano","year":"2017","unstructured":"Sano T, et al. Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer. 2017;20(2):217\u201325.","journal-title":"Gastric Cancer"},{"key":"1219_CR25","doi-asserted-by":"crossref","unstructured":"Deng J et al. Validation of clinical significance of examined lymph node count for accurate prognostic evaluation of gastric cancer for the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system. Chin J Cancer Res. 2018;30(5): 477-491.","DOI":"10.21147\/j.issn.1000-9604.2018.05.01"},{"issue":"5","key":"1219_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1056\/NEJMoa0707035","volume":"359","author":"M Sasako","year":"2008","unstructured":"Sasako M, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359(5):453\u201362.","journal-title":"N Engl J Med"},{"issue":"2","key":"1219_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.radonc.2018.07.002","volume":"129","author":"JI Yu","year":"2018","unstructured":"Yu JI, et al. Necessity of adjuvant concurrent chemo-radiotherapy in D2-resected LN-positive gastric cancer. Radiother Oncol. 2018;129(2):306\u201312.","journal-title":"Radiother Oncol"},{"issue":"3","key":"1219_CR28","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.annonc.2020.11.017","volume":"32","author":"SH Park","year":"2021","unstructured":"Park SH, et al. A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial(\u2606). Ann Oncol. 2021;32(3):368\u201374.","journal-title":"Ann Oncol"},{"issue":"3","key":"1219_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/COC.0b013e31820dbf08","volume":"35","author":"R Shridhar","year":"2012","unstructured":"Shridhar R, et al. Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis. Am J Clin Oncol. 2012;35(3):216\u201321.","journal-title":"Am J Clin Oncol"},{"key":"1219_CR30","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.2147\/CMAR.S195130","volume":"11","author":"ML Zhou","year":"2019","unstructured":"Zhou ML, et al. Adjuvant chemoradiotherapy versus adjuvant chemotherapy for patients with N3 gastric cancer after D2\/R0 resection: a retrospective study based on propensity score analyses. Cancer Manag Res. 2019;11:4855\u201370.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"1219_CR31","doi-asserted-by":"publisher","first-page":"9008","DOI":"10.1038\/s41598-024-59516-3","volume":"14","author":"Q Wang","year":"2024","unstructured":"Wang Q, et al. Development and validation of a nomogram to predict cancer-specific survival of elderly patients with unresected gastric cancer who received chemotherapy. Sci Rep. 2024;14(1):9008.","journal-title":"Sci Rep"},{"issue":"4","key":"1219_CR32","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jamcollsurg.2014.03.062","volume":"219","author":"G Spolverato","year":"2014","unstructured":"Spolverato G, et al. Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis. J Am Coll Surg. 2014;219(4):664\u201375.","journal-title":"J Am Coll Surg"},{"issue":"11","key":"1219_CR33","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.4240\/wjgs.v13.i11.1351","volume":"13","author":"Y Kawaguchi","year":"2021","unstructured":"Kawaguchi Y, et al. Is surgery the best treatment for elderly gastric cancer patients? World J Gastrointest Surg. 2021;13(11):1351\u201360.","journal-title":"World J Gastrointest Surg"},{"issue":"5","key":"1219_CR34","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.ijrobp.2005.05.005","volume":"63","author":"S Kim","year":"2005","unstructured":"Kim S, et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys. 2005;63(5):1279\u201385.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9813","key":"1219_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","volume":"379","author":"YJ Bang","year":"2012","unstructured":"Bang YJ, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315\u201321.","journal-title":"Lancet"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01219-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01219-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01219-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T09:33:22Z","timestamp":1747906402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01219-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1219"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01219-7","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"28 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study used previously collected anonymized and de-identified data from the SEER database, which does not require Institutional Review Board approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"122"}}